Update on molecular-targeted therapy in hematologic malignancies

被引：0
作者：
Takanori Ueda
机构：
[1] University of Fukui,Department of Hematology and Oncology, Faculty of Medical Sciences
来源：
International Journal of Clinical Oncology | 2007年 / 12卷
关键词：
Imatinib; Acute Promyelocytic Leukemia; Chronic Myelogenous Leukemia; Imatinib Mesylate; Acute Promyelocytic Leukemia Cell;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：311 / 312
页数：1
相关论文
共 50 条
[41]   Acute Pulmonary Complications in Patients with Hematologic Malignancies [J].
Choi, Moon Hyung ;
Jung, Jung Im ;
Chung, Woong Do ;
Kim, Yoo-Jin ;
Lee, Sung-Eun ;
Han, Dae Hee ;
Ahn, Myeong Im ;
Park, Seog Hee .
RADIOGRAPHICS, 2014, 34 (06) :1755-1768
[42]   Epigenetic Modulation in Hematologic Malignancies: Challenges and Progress [J].
Mitsiades, Constantine S. ;
Anderson, Kenneth C. .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2009, 7 :S1-S12
[43]   Cost-effectiveness of kinase inhibitors for hematologic malignancies: a systematic and critical review [J].
Marchetti, Monia .
EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2017, 17 (05) :469-480
[44]   Health Care Cost Associated With Contemporary Chronic Myelogenous Leukemia Therapy Compared With That of Other Hematologic Malignancies [J].
Wilkes, Jennifer J. ;
Lyman, Gary H. ;
Doody, David R. ;
Chennupati, Shasank ;
Becker, Laura K. ;
Morin, Pamela E. ;
Winestone, Lena E. ;
Henk, Henry J. ;
Chow, Eric J. .
JCO ONCOLOGY PRACTICE, 2021, 17 (03) :147-+
[45]   Cutaneous Adverse Events of Targeted Therapies for Hematolymphoid Malignancies [J].
Ransohoff, Julia D. ;
Kwong, Bernice Y. .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12) :834-851
[46]   Structural Variants as a Basis for Targeted Therapies in Hematological Malignancies [J].
Schuette, Judith ;
Reusch, Julia ;
Khandanpour, Cyrus ;
Eisfeld, Christine .
FRONTIERS IN ONCOLOGY, 2019, 9
[47]   Targeted Therapies for Thymic Malignancies [J].
Girard, Nicolas .
THORACIC SURGERY CLINICS, 2011, 21 (01) :115-+
[48]   Targeted therapies for gynecologic malignancies [J].
Hyde J. ;
McMeekin D.S. .
Current Treatment Options in Oncology, 2005, 6 (2) :121-132
[49]   Overview of Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies [J].
Singh, Nathan ;
Loren, Alison W. .
CLINICS IN CHEST MEDICINE, 2017, 38 (04) :575-+
[50]   Management of Hematologic Malignancies: Special Considerations in Pregnant Women [J].
Odelia Amit ;
Merav Barzilai ;
Irit Avivi .
Drugs, 2015, 75 :1725-1738
12345